Latest National Cancer Institute Stories
LAUSANNE, Switzerland, November 18, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs
LAS VEGAS, November 17, 2014 /PRNewswire/ -- EnzymeBioSystems (OTCBB: ENZB) announces, methyl amooranin, its lead pharmaceutical product, shows promise in preventing breast cancer.
PILOT PROJECT TO BOOST DATA SHARING, ACCESSIBILITY CAMBRIDGE, Mass., Oct.
Award furthers research on 3D bioprinting of nipple areola complex for reconstruction in breast cancer survivors Austin, Texas (PRWEB) October 30, 2014
The Mesothelioma Applied Research Foundation (Meso Foundation) congratulates former Science Advisory Board member and researcher at the National Cancer Institute, Raffit Hassan, MD, for receiving
Cancer is a real concern for many people. The concern may come from a genetic predisposition, environmental triggers, or simply the health-conscious need to have a better understanding of the diseases.
RadioMedix, Inc., a Houston-based biotechnology company and Viewpoint Molecular Targeting LLC of Iowa City were awarded a grant by the Small Business Innovation Research (SBIR) program from the
SAN DIEGO, Oct.
NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of
- Of or relating to good digestion.